Bartholomew G Logan, Karas Lucas J, Eason Reilly M, Yeung Charles S, Sigman Matthew S, Sarpong Richmond
Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States.
Department of Chemistry, University of Utah, Salt Lake City, Utah 84112, United States.
J Med Chem. 2025 Mar 27;68(6):6027-6040. doi: 10.1021/acs.jmedchem.4c02839. Epub 2025 Mar 7.
Heteroaromatics are the basis for many pharmaceuticals. The ability to modify these structures through selective core-atom transformations, or "skeletal edits", can dramatically expand the landscape for drug discovery and development. However, despite the importance of core-atom modifications, the quantitative impact of such transformations on accessible chemical space remains undefined. Here, we report a cheminformatic platform to analyze which skeletal edits would most increase access to novel chemical space. This study underscores the significance of emerging single and multiple core-atom transformations of heteroaromatics in enhancing chemical diversity, for example, at a late-stage of a drug discovery campaign. Our findings provide a quantitative framework for prioritizing core-atom modifications in heteroaromatic structural motifs, calling for the development of new methods to achieve these types of transformations.
杂环芳烃是许多药物的基础。通过选择性的核心原子转化或“骨架编辑”来修饰这些结构的能力,可以极大地拓展药物发现和开发的领域。然而,尽管核心原子修饰很重要,但这种转化对可及化学空间的定量影响仍不明确。在此,我们报告了一个化学信息学平台,用于分析哪些骨架编辑最能增加对新型化学空间的可及性。这项研究强调了杂环芳烃新出现的单核心原子和多核心原子转化在增强化学多样性方面的重要性,例如在药物发现活动的后期。我们的研究结果为在杂环芳烃结构基序中优先进行核心原子修饰提供了一个定量框架,呼吁开发新方法来实现这类转化。